228 related articles for article (PubMed ID: 17462991)
1. Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells.
Khan S; Bijker MS; Weterings JJ; Tanke HJ; Adema GJ; van Hall T; Drijfhout JW; Melief CJ; Overkleeft HS; van der Marel GA; Filippov DV; van der Burg SH; Ossendorp F
J Biol Chem; 2007 Jul; 282(29):21145-59. PubMed ID: 17462991
[TBL] [Abstract][Full Text] [Related]
2. Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells.
Khan S; Weterings JJ; Britten CM; de Jong AR; Graafland D; Melief CJ; van der Burg SH; van der Marel G; Overkleeft HS; Filippov DV; Ossendorp F
Mol Immunol; 2009 Mar; 46(6):1084-91. PubMed ID: 19027958
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells.
Heit A; Maurer T; Hochrein H; Bauer S; Huster KM; Busch DH; Wagner H
J Immunol; 2003 Mar; 170(6):2802-5. PubMed ID: 12626528
[TBL] [Abstract][Full Text] [Related]
4. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs.
Kool M; Geurtsvankessel C; Muskens F; Madeira FB; van Nimwegen M; Kuipers H; Thielemans K; Hoogsteden HC; Hammad H; Lambrecht BN
J Leukoc Biol; 2011 Dec; 90(6):1177-90. PubMed ID: 21934071
[TBL] [Abstract][Full Text] [Related]
5. Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4(+) T cells.
Mantegazza AR; Guttentag SH; El-Benna J; Sasai M; Iwasaki A; Shen H; Laufer TM; Marks MS
Immunity; 2012 May; 36(5):782-94. PubMed ID: 22560444
[TBL] [Abstract][Full Text] [Related]
6. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.
Datta SK; Redecke V; Prilliman KR; Takabayashi K; Corr M; Tallant T; DiDonato J; Dziarski R; Akira S; Schoenberger SP; Raz E
J Immunol; 2003 Apr; 170(8):4102-10. PubMed ID: 12682240
[TBL] [Abstract][Full Text] [Related]
7. Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients.
Dou Y; Jansen DTSL; van den Bosch A; de Man RA; van Montfoort N; Araman C; van Kasteren SI; Zom GG; Krebber WJ; Melief CJM; Woltman AM; Buschow SI
Antiviral Res; 2020 Jun; 178():104746. PubMed ID: 32081741
[TBL] [Abstract][Full Text] [Related]
8. CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].
de Brito C; Tomkowiak M; Ghittoni R; Caux C; Leverrier Y; Marvel J
J Immunol; 2011 Feb; 186(3):1503-11. PubMed ID: 21187449
[TBL] [Abstract][Full Text] [Related]
9. Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugates.
Zom GG; Khan S; Britten CM; Sommandas V; Camps MG; Loof NM; Budden CF; Meeuwenoord NJ; Filippov DV; van der Marel GA; Overkleeft HS; Melief CJ; Ossendorp F
Cancer Immunol Res; 2014 Aug; 2(8):756-64. PubMed ID: 24950688
[TBL] [Abstract][Full Text] [Related]
10. The immunogenicity of CpG-antigen conjugates.
Wagner H
Adv Drug Deliv Rev; 2009 Mar; 61(3):243-7. PubMed ID: 19174176
[TBL] [Abstract][Full Text] [Related]
11. Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication.
Zom GG; Willems MMJHP; Khan S; van der Sluis TC; Kleinovink JW; Camps MGM; van der Marel GA; Filippov DV; Melief CJM; Ossendorp F
J Immunother Cancer; 2018 Dec; 6(1):146. PubMed ID: 30541631
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
13. Tubulation of endosomal structures in human dendritic cells by Toll-like receptor ligation and lymphocyte contact accompanies antigen cross-presentation.
Compeer EB; Flinsenberg TW; Boon L; Hoekstra ME; Boes M
J Biol Chem; 2014 Jan; 289(1):520-8. PubMed ID: 24235148
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.
Mouriès J; Moron G; Schlecht G; Escriou N; Dadaglio G; Leclerc C
Blood; 2008 Nov; 112(9):3713-22. PubMed ID: 18698004
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
Lindsay RW; Darrah PA; Quinn KM; Wille-Reece U; Mattei LM; Iwasaki A; Kasturi SP; Pulendran B; Gall JG; Spies AG; Seder RA
J Immunol; 2010 Aug; 185(3):1513-21. PubMed ID: 20610651
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells.
Shen KY; Song YC; Chen IH; Leng CH; Chen HW; Li HJ; Chong P; Liu SJ
J Immunol; 2014 May; 192(9):4233-41. PubMed ID: 24683188
[TBL] [Abstract][Full Text] [Related]
17. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
[TBL] [Abstract][Full Text] [Related]
18. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.
Dillon S; Agrawal A; Van Dyke T; Landreth G; McCauley L; Koh A; Maliszewski C; Akira S; Pulendran B
J Immunol; 2004 Apr; 172(8):4733-43. PubMed ID: 15067049
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus PSM peptides induce tolerogenic dendritic cells upon treatment with ligands of extracellular and intracellular TLRs.
Armbruster NS; Richardson JR; Schreiner J; Klenk J; Günter M; Autenrieth SE
Int J Med Microbiol; 2016 Dec; 306(8):666-674. PubMed ID: 27616282
[TBL] [Abstract][Full Text] [Related]
20. Regulation of dendritic cell function through Toll-like receptors.
Kaisho T; Akira S
Curr Mol Med; 2003 Jun; 3(4):373-85. PubMed ID: 12776992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
